Login to Your Account

Financings Roundup

Merrimack Follows Clovis into IPO Queue with $172.5M Filing

By Trista Morrison

Tuesday, July 12, 2011
Who's afraid of the big, bad initial public offering (IPO) market? Apparently not cancer firm Merrimack Pharmaceuticals Inc., which filed late Friday to raise up to $172.5 million in an IPO. Apparently not J.P. Morgan, either. The investment bank is listed on Merrimack's book as well as on the book for Clovis Oncology Inc., which last month filed to raise up to $149.5 million in an IPO. (See BioWorld Today, June 24, 2011.)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription